Macrocyclic compounds and uses thereof
US11814398B2 · kind B2 · utility
1Cited by
38References
32Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 23, 2022 |
| Grant date | Nov 14, 2023 |
| Priority date | — |
| Expiry date | Jun 23, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds (e.g., compounds of Formulae (I), (II), (III), (IV)) having tumor vascular remodeling effect and/or anti-CAF (Cancer Associated Fibroblasts) activity, or pharmaceutically acceptable salts thereof, optionally in a pharmaceutically acceptable carrier, and a medical uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.